Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,181.0
-17.6 (-0.55%)

 

  • STI Straits Times Index
    3,181.0
    -17.6 (-0.55%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,531.2
    -3.8 (-0.25%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    27,308.8
    -300.3 (-1.09%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,039.7
    9.5 (0.31%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,386.7
    -92.4 (-0.39%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,882.3
    -60.2 (-1.01%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,078.9M
  • Value: 1,171.0M
  • Rise: 88
  • Fall: 225
  • Unch: 501

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
AusGroup^0.048-0.004
Rex Intl0.193-0.007
Ntegrator Intl0.008-0.002
Medtecs Intl0.097+0.001
Ley Choon0.019+0.001
YZJ Shipbldg SGD1.040-
Singtel3.100-0.030
ComfortDelGro2.020-0.030
Genting Sing0.880-
Dyna-Mac0.134-0.016

World Indices

World Indices
Name Last Change
Nasdaq 9,751.0 -66.2
HSI 27,308.8 -300.4
HSCEI 10,790.8 -123.1
Jakarta 5,882.3 -60.2
Nikkei 225 23,386.7 -92.4
SSE Comp 3,039.7 +9.5
Shanghai A 3,185.3 +10.0
Shanghai B 244.9 +0.8
KOSPI 2,162.8 -32.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

CHINA BIOLOGIC PRODUCTS HLDGS INC CHINA BIOLOGIC PRODUCTS HLDGS INC
Updated on 20 Feb 2020 (End of trading day)
Last (USD): 116.820 Change: +0.210 High: 117.000 Remarks: -
Change (%): +0.18 Low: 116.270
Open 116.270 Yesterday's Close 116.61
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 93,546 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a 3.25082 Trailing EPS (USD) e 4.19443 NAV (USD) b 43.1361
PE a 35.936 Trailing PE f 27.851 Price / NAV b 2.7082
Dividend (USD) d - Cash In Hand (USD) g 5.7443 Issued & Paid-up Shares c 38,447,000
Dividend Yield (%) d - Price / Cash In Hand g 20.337 Treasury Shares h 3,450,932
Beta - 75 Daysi 0.137 R-Squared - 75 Days(%)i 3.34 Market Cap (M) 4,491.379
Beta - 500 Daysi 0.041 R-Squared - 500 Days (%)i 0.04 Enterprise Value (M) 3,723.973
Piotroski F Score 6 Exchange Code CBPO Par Value ( $ ) n.a.
52 Weeks Volatility (%) 19.65 Free Float (%) 48.3
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 15 Nov 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 06 Aug 2019.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference CHINA BIOLOGIC PRODUCTS HLDGS INC NASDAQ 4,491.379 35.936 27.851 2.7082 -
Industry Biotechnology NASDAQ 2,486.502 316.473 197.808 6.0943 0.731
Local Peer AMGEN INC NASDAQ 131,019.727 15.609 16.707 13.5449 2.537
Local Peer GILEAD SCIENCES INC NASDAQ 84,822.000 15.549 15.749 3.7449 3.446
Local Peer VERTEX PHARMACEUTICAL NASDAQ 63,546.832 30.312 53.999 10.4428 -
Local Peer BIOGEN INC NASDAQ 58,596.905 13.225 9.951 4.3915 -
Local Peer ILLUMINA INC NASDAQ 44,167.620 53.472 44.079 9.5746 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 43,913.371 17.965 20.755 3.9598 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 22,702.459 292.553 9.442 2.0141 -
Local Peer SEATTLE GENETICS INC NASDAQ 20,383.526 - - 10.8637 -
Local Peer INCYTE CORPORATION NASDAQ 17,942.550 163.869 40.148 6.9052 -
Local Peer GALAPAGOS NV SPON ADR REPR 1 ORD SHS NASDAQ 16,816.007 - 54.182 6.0840 -
Local Peer BIOMARIN PHARMACEUTICAL NASDAQ 16,105.177 - - 5.2385 -
Local Peer EXACT SCIENCES CORP NASDAQ 15,111.892 - - 6.6047 -
Other Local Peers ALNYLAM PHARMACEUTICALS INC (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), MODERNA INC (NASDAQ), EXELIXIS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), BLUEBIRD BIO INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), FIBROGEN INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ALKERMES PLC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), UNIQURE N.V. (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), ALECTOR INC (NASDAQ), EPIZYME INC (NASDAQ), VIELA BIO INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), XENCOR INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), REGENXBIO INC (NASDAQ), ARVINAS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), EDITAS MEDICINE INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), NEXTCURE INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), VERACYTE INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), DERMIRA INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), IMMUNOGEN INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), CYTOKINETICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), AVROBIO INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), PRECIGEN INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), ARDELYX INC (NASDAQ), RETROPHIN INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), OMEROS CORP (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), COMPUGEN (NASDAQ), UROGEN PHARMA LTD (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), XBIOTECH INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), NANTKWEST INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), KURA ONCOLOGY INC (NASDAQ), MERUS B V (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), AGENUS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), PROTHENA CORP PLC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), CABALETTA BIO INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), PERSONALIS INC (NASDAQ), IVERIC BIO INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), ADURO BIOTECH INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), KAMADA (NASDAQ), VBI VACCINES INC CDA (NASDAQ), SERES THERAPEUTICS (NASDAQ), GERON CORP (NASDAQ), NOVAVAX INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), XOMA CORP (NASDAQ), MEDICINOVA INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), IMV INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), AFFIMED N V (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), ATHERSYS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), CHIASMA INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), GLYCOMIMETICS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), VERASTEM INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), CELYAD ADS EACH REPR 1 ORD (NASDAQ), ARAVIVE INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), INFLARX N V (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), SAVARA INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), OTONOMY INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), CHIMERIX INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), VACCINEX INC (NASDAQ), ORGENESIS INC (NASDAQ), SESEN BIO INC (NASDAQ), SYNLOGIC INC (NASDAQ), EQUILLIUM INC (NASDAQ), VERMILLION INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), COHBAR INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), TREVENA INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), SOLIGENIX INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), ADVAXIS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), INMUNE BIO INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), RESTORBIO INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), VAXART INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), CURIS INC (NASDAQ), ZAFGEN INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), EVOGENE LTD (NASDAQ), ATYR PHARMA INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), BIOCARDIA INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), OCUGEN INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), SOPHIRIS BIO INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), TOCAGEN INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), PRECIPIO INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), BENITEC BIOPHARMA LTD SPON ADS EA REPR 200 ORD SHS(POST SPLIT) (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), SENESTECH INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), SPHERIX INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ)
Global Peer CSL ASX 152,685.905 56.910 52.709 - 0.789
Global Peer AMGEN-T HKEx 589,807.000 8.965 9.598 7.8255 4.417
Global Peer AGILENT TECHNOLOGIES INC NYSE 26,210.173 82.943 46.226 - 0.723
Global Peer WUXI BIO HKEx 150,187.318 201.078 157.198 15.4600 -
Global Peer SINO BIOPHARM HKEx 141,341.355 13.191 13.690 4.2093 0.651
Global Peer BEIGENE HKEx 101,119.536 - - 10.0893 -
Global Peer GENSCRIPT BIO HKEx 32,940.950 198.098 - 9.2892 -
Global Peer Lonza SGX 5,937.453 6.613 6.613 0.6568 4.787
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 3,333.878 53.172 775.320 3.2211 -
Global Peer 3SBIO HKEx 26,009.293 17.193 20.927 2.5635 -
Other Global Peers ALPHAMAB-B (HKEx), HAOHAI BIOTEC (HKEx), POLYNOVO LIMITED (ASX), FRONTAGE (HKEx), AVITA MEDICAL LTD (ASX), MYOVANT SCIENCES LTD (NYSE), MESOBLAST LTD (ASX), VIVA BIOTECH (HKEx), KADMON HLDGS INC (NYSE), ARCUS BIOSCIENCES INC (NYSE), ASCENTAGE-B (HKEx), ASCLETIS-B (HKEx), SINOMAB BIO-B (HKEx), ESSEX BIO-TECH (HKEx), NANOVIRICIDES INC (NYSE American), LEE'S PHARM (HKEx), PFENEX INC (NYSE American), TELIX PHARMACEUTIC (ASX), DPHARMA (Bursa), BBI LIFE SCI (HKEx), NEXT SCIENCE LTD (ASX), LINEAGE CELL THERAPEUTICS INC (NYSE American), NEUREN PHARMACEUTICALS LTD (ASX), CEL-SCI CORP (NYSE American), UNI-BIO GROUP (HKEx), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), ENZO BIOCHEM INC (NYSE), IMMUTEP LTD (ASX), 22ND CENTURY GROUP INC (NYSE American), IMUGENE LIMITED (ASX), PALATIN TECHNOLOGIES INC (NYSE American), CYNATA THERAPEUTICS LTD (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), BIOTRON (ASX), CT ENTERPRISE (HKEx), ARMATA PHARMACEUTICALS INC (NYSE American), INVEX THERAPEUTICS LTD NPV (ASX), BIOSINO BIO-TEC (HKEx), IBIO INC (NYSE American), HOLISTA COLLTECH LIMITED (ASX), MEMPHASYS LTD (ASX), CCP TECHNOLOGIES LTD (ASX), REGENT PACIFIC (HKEx), ORAGENICS INC (NYSE American), KAZIA THERAPEUTICS LIMITED (ASX), ANTEOTECH LIMITED (ASX), GENETIC TECHNOLOGIES (ASX), BIONOMICS LTD (ASX), ACTINOGEN MEDICAL LTD (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), INDIA GLOBALIZATION CAPITAL INC (NYSE American), RHINOMED LIMITED (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), Suntar Eco-City^ (SGX), REGENEUS LTD (ASX), PATRYS LIMITED (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), SIENNA CANCER DIAGNOSTICS LTD (ASX), ADALTA LTD (ASX), AIM IMMUNOTECH INC (NYSE American), NOVABAY PHARMACEUTICALS INC (NYSE American), BENITEC BIOPHARMA LTD (ASX), ANATARA LIFESCIENCES LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), HAO WEN HLDGS (HKEx), LIVING CELL TECHNOLOGIES (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), LEAF RESOURCES LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), NANOLLOSE LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX), CRYOSITE (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.040
+0.03 %
10 Days -+0.590
+0.51 %
20 Days -+1.470
+1.27 %
Medium Term Return 3 Months -+0.100
+0.09 %
6 Months -+18.960
+19.37 %
1 Year -+36.020
+44.58 %
Long Term Return 2 Years -+31.640
+37.14 %
3 Years -+7.720
+7.08 %
5 Years -+40.220
+52.51 %
Annualised Return Annualised --
+8.81 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 79.060 - 119.440 Change From 1 Year Low +37.760 % Change From 1 Year Low (%) +47.76
Change From 1 Year High -2.620 % Change From 1 Year High (%) -2.19
2 Years Range 60.080 - 119.440 Change From 2 Years Low +56.740 % Change From 2 Years Low (%) +94.44
Change From 2 Years High -2.620 % Change From 2 Years High (%) -2.19
5 Years Range 60.080 - 144.290 Change From 5 Years Low +56.740 % Change From 5 Years Low (%) +94.44
Change From 5 Years High -27.470 % Change From 5 Years High (%) -19.04
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

China Biologic Products Holdings, Inc. engages in the research, development, manufacture and sale of human plasma-based biopharmaceutical products or plasma products. Its products include plasma and other products. The company was founded in 2002 and is headquartered in Beijing, China.

Historical Price Data

Date Open High Low Close Volume VWAP
20 Feb 2020 116.270 117.000 116.270 116.820 93,546 -
19 Feb 2020 116.440 116.790 116.195 116.610 80,242 -
18 Feb 2020 116.670 116.700 116.020 116.380 98,160 -
14 Feb 2020 116.580 117.000 115.750 116.780 100,009 -
13 Feb 2020 116.320 116.740 115.550 116.490 121,564 -
12 Feb 2020 116.710 117.040 115.756 116.310 133,054 -
11 Feb 2020 116.500 117.100 116.110 117.100 115,372 -
10 Feb 2020 116.350 116.550 115.950 116.360 88,006 -
07 Feb 2020 116.620 116.950 116.050 116.230 83,004 -
06 Feb 2020 116.500 117.000 116.020 116.950 139,683 -
05 Feb 2020 116.000 117.000 115.770 116.360 107,376 -
04 Feb 2020 116.000 116.910 115.550 116.000 112,604 -
03 Feb 2020 115.510 116.770 115.045 115.930 85,395 -
31 Jan 2020 116.170 117.500 115.410 115.900 154,138 -
30 Jan 2020 116.040 116.740 115.330 116.170 50,892 -
29 Jan 2020 115.610 116.690 115.470 116.590 53,766 -
28 Jan 2020 115.860 116.715 115.860 116.100 39,149 -
27 Jan 2020 115.010 116.480 115.010 115.940 35,483 -
24 Jan 2020 116.490 117.000 115.340 115.350 124,343 -
23 Jan 2020 116.450 116.800 116.015 116.470 103,275 -
22 Jan 2020 116.840 116.865 115.460 116.450 66,353 -
21 Jan 2020 115.800 116.760 115.630 116.380 89,764 -
Summary
Current 2 Weeks
(06 Feb 2020 to 20 Feb 2020)
116.500 117.100 115.550 116.820 1,052,640 -
Previous 2 Weeks
(23 Jan 2020 to 05 Feb 2020)
116.450 117.100 115.550 116.360 866,421 -
4 Weeks from
(23 Dec 2019 to 22 Jan 2020)
116.990 117.190 115.550 116.450 1,701,006 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.